Citra Marga Nusaphala Persada Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Citra Marga Nusaphala Persada Tbk. trades at Rp1,345 (market cap 9.11T, 96.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Citra Marga Nusaphala Persada Tbk. is far larger — about 54.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Citra Marga Nusaphala Persada Tbk. is more actively traded (96.2K versus 71K). Which is the better fit depends on your goals.
| CMNP | OBAT | |
|---|---|---|
Market Cap | 9.11T | 167.37B |
Volume | 96.2K | 71K |
Lot | 962 | 710 |
Turnover | 129.18M | 17.51M |
Average Price | 1,342.87 | 246.63 |
Value | 129.18M | 17.51M |
Indicative Equilibrium Price | 1,345 | 246 |
Indicative Equilibrium Volume | 2 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Marga Nusaphala Persada Tbk (the Company) was established within the framework of the Domestic Investment Law No. 6 of 1968, as amended by Law No. 12 of 1970 based on Notarial Deed No. 58 dated April 13, 1987 of Kartini Muljadi, S.H.The Company derives its revenues primarily from tollgate proceeds, project management fees and, to a lesser extent, from services related to the operations of a toll way system. The Company started commercial operations on March 1990. On June 19th, 1996, the Tanjung Priok – Jembatan Tiga toll road started commercial operations.
Read more on CMNP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →